64/100
Opportunity
Commercial fit17/25
Clinical timing20/20
Biomarker need10/20
Relationship2/10
Signal strength9/10
Account value5/10
Urgency1/5
New phase 1 trial NCT07594067 posted by University of Pennsylvania: "TCR1188-ABC Cells in KRAS-mutated Cancers". New trial on a phase 1 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).
Why nowClinicalTrials.gov record updated 33 days ago.
ConfidenceHigh · 95%